Testing a skin imaging device for non-melanoma skin cancer
Part of Cancer, Skin clinical trials.
This study tests a device that uses a special light to image skin lesions after applying an FDA-approved cream. It aims to see if the device can help doctors see benign skin growths more clearly before they are removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a non-melanoma skin cancer confirmed by biopsy.
- You have a skin lesion scheduled for removal, and it measures between 5 mm and 3 cm (about the size of a pencil eraser to a large grape).
- You are willing and able to follow study procedures.
- If you are a woman who can become pregnant, you must have a negative pregnancy test before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device placed on skin cancer lesions to see which drugs might work best. It is for people with visible squamous cell carcinoma on the skin, including lesions that have come back after radiation.
This early trial tests whether adding vitamin A and niacinamide (a form of vitamin B3) can help people with a history of certain skin cancers reduce new disease. It is designed for adults with specific prior skin cancer or skin lesion treatment patterns.
This study tests a device that takes a close-up picture of a suspicious mole to estimate how deep the melanoma is before surgery. This might help doctors plan surgery more accurately.
This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.
This trial is testing a special light-based technique (Raman spectroscopy) to see if it can help doctors better identify skin cancers. It is for people with either basal cell or squamous cell carcinoma who are scheduled to receive brachytherapy treatment.
This study tests a new device called LumAssure that scans skin to help doctors look at skin conditions. It aims to see if the device works well for people with different skin issues.
Hear when a new Non-Melanoma Skin Cancer (NMSC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.